Why did the use of the Johnson & Johnson vaccine pause?
Recently, the Centers for Disease Control (CDC) recommended a temporary pause in using the Johnson & Johnson (J&J) vaccine. This was because of a rare type of blood clot (called thrombosis) in 6 people after receiving the vaccine. This blood clot was very rare, occurring at a rate of 7 per 1 million vaccinated women aged 18 to 49 years. The blood clot related to the vaccine is even less likely for women 50 years and older. Although it was rare, medical teams from the CDC and U.S. Food & Drug Administration (FDA) did safety reviews and looked at the data during the pause to better understand the risk of this blood clot related to receiving the vaccine.
CDC recommends use of Johnson & Johnson vaccine
After the safety reviews, the CDC and FDA now recommend that the J&J vaccine resume in the United States. The CDC and FDA are confident that the vaccine is safe and effective in preventing COVID-19. They found that the J&J vaccine’s benefits are much greater than any potential risks in people aged 18 or older. However, women younger than 50 years old should still be aware of their risk of this very rare type of blood clot.